Roche: Our upcoming diabetes drug works better than Byetta. Will be interesting to see the full set of data.
AstraZeneca’s experimental oncology drug Zactima: let’s step back for a time-out.
Genta: time to give up on Genasense? Not sure this horse is ever going to gallop.
Compliance Training. Impactiviti’s partner network includes solutions providers for every level of compliance training – from sales reps to home office employees. Ethics, Regulatory compliance, Diversity – you name it. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.
This week, I attended a very enjoyable ePatient Connection conference (put on by Kevin Kruse). It was excellent: here’s a review.
JUST FOR FUN
Nov. 3-4 – eyeforpharma’s 4th Annual eCommunication and On-line Marketing Summit, Philadelphia, PA. I’ll be part of a panel on social networking, and live-blogging/Twittering. Here’s a discount code to save $400 off your registration: SPEAK
Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)
Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)
Connect with Steve Woodruff
Leave a Reply